Viewing Study NCT02339103


Ignite Creation Date: 2025-12-24 @ 7:25 PM
Ignite Modification Date: 2026-01-04 @ 5:31 PM
Study NCT ID: NCT02339103
Status: COMPLETED
Last Update Posted: 2018-11-26
First Post: 2015-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Heat and Intravenous Fluids for Exogenous Rewarming
Sponsor: Stanford University
Organization:

Study Overview

Official Title: Study of Heat and Intravenous Fluids for Exogenous Rewarming (SHIVER)
Status: COMPLETED
Status Verified Date: 2018-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SHIVER
Brief Summary: The purpose of this study is to compare two novel active rewarming techniques in mildly hypothermic people. Volunteers will undergo 3 cooling trials in a circulating bath at 14 degrees celsius and will then be rewarmed with either shivering alone, warmed iv fluids (IVF), or water perfusion pads applied to the hands and feet. The investigators hypothesize that both heated IVF and water perfusion pads to the arteriovenous anastomoses (AVAs) will prove to provide significantly superior rewarming rates than shivering alone.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: